Showing results (61-70 of 101) with videos related to
Sort By:
Pageof 11
Cell Cycle (Georgetown, Tex.)|May 7, 2005
Mutated PI 3-kinases: cancer targets on a silver platterSohye Kang, Andreas G Bader, Li Zhao, et al.International Journal of Cancer|October 31, 2009
Phosphatidylinositol 4,5-bisphosphate-specific AKT1 is oncogenicNadine Dannemann, Jonathan Ross Hart, Lynn Ueno, et al.Nature Reviews. Cancer|December 13, 2005
Oncogenic PI3K deregulates transcription and translationAndreas G Bader, Sohye Kang, Li Zhao, et al.Trends in Biochemical Sciences|June 15, 2007
Cancer-specific mutations in phosphatidylinositol 3-kinasePeter K Vogt, Sohye Kang, Marc-André Elsliger, et al.Proceedings of the National Academy of Sciences of the United States of America|September 12, 2022
Nanobodies and chemical cross-links advance the structural and functional analysis of PI3KαJonathan R Hart, Xiao Liu, Chen Pan, et al.Cell Cycle (Georgetown, Tex.)|May 26, 2012
Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescenceMarina Kolesnichenko, Lixin Hong, Rong Liao, et al.Molecular Cancer Research : MCR|July 9, 2009
Requirement of phosphatidylinositol(3,4,5)trisphosphate in phosphatidylinositol 3-kinase-induced oncogenic transformationAdam Denley, Marco Gymnopoulos, Sohye Kang, et al.Oncogene|May 11, 2004
v-Jun targets showing an expression pattern that correlates with the transformed cellular phenotypeJason S Iacovoni, Steven B Cohen, Thorsten Berg, et al.Oncogene|October 9, 2002
Oncogenic transformation by beta-catenin: deletion analysis and characterization of selected target genesMasahiro Aoki, Vera Sobek, Daniel J Maslyar, et al.Journal of Cellular Physiology|August 3, 2006
A downstream kinase of the mammalian target of rapamycin, p70S6K1, regulates human double minute 2 protein phosphorylation and stabilityJing Fang, Qiao Meng, Peter K Vogt, et al.Pageof 11